1 year return (CAGR)
683.43%
Erasca Inc Exchange (NASDAQ, USD)
ERAS
13.95
-1.60 (-10.32%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
78.79%
5 year return (CAGR)
-7.90%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.88B
Price/Sales
-
Ent value
4.91B
Price/Book
13.48
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-21.59%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 15.55 |
| Daily high | 15.55 |
| Daily low | 13.94 |
| Daily Volume | 4.42M |
| All-time high | 24.34 |
| 1y analyst estimate | 24.30 |
| Beta | 0.65 |
| EPS (TTM) | -0.92 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ERAS | S&P500 | |
| Current price drop from All-time high | -42.71% | -1.29% |
| Highest price drop | -95.64% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -72.13% | -10.68% |
| Avg time to new high | 82 days | 12 days |
| Max time to new high | 1269 days | 1805 days |
News
